What is the protocol for conducting a daily spontaneous breathing trial (SBT) in a mechanically ventilated patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Conduct a Daily Spontaneous Breathing Trial

Perform a 30-minute spontaneous breathing trial using pressure support ventilation (5-8 cmH₂O) with PEEP ≤5 cmH₂O rather than T-piece alone, as this approach significantly increases successful extubation rates (82.3% vs 74.0%) and reduces mortality. 1, 2, 3

Patient Selection Criteria

Before initiating an SBT, verify that the patient meets ALL of the following readiness criteria:

  • Arousable and adequate mental status 4, 2
  • Hemodynamically stable without vasopressor agents 4, 2
  • FiO₂ <0.50 (50%) 2
  • PEEP ≤5 cmH₂O 4, 2
  • No new potentially serious conditions 4, 2
  • Resolution or improvement of the primary indication for mechanical ventilation 2
  • Intact airway reflexes and ability to protect airway 2

SBT Protocol and Settings

Use pressure support ventilation of 5-8 cmH₂O with PEEP of 5 cmH₂O for the initial trial. 4, 2, 3 This approach is superior to T-piece alone, which may be overly stringent and unnecessarily delay extubation in patients who could successfully extubate. 3

The evidence strongly supports this method:

  • SBT success rate: 84.6% with pressure support vs 76.7% with T-piece 2
  • Extubation success rate: 75.4% with pressure support vs 68.9% with T-piece 2
  • Significantly higher successful extubation at 72 hours (82.3% vs 74.0%, P=0.001) 1

Duration of the Trial

Conduct a 30-minute SBT for standard-risk patients. 2, 1 This shorter duration is sufficient for most patients and has been validated in large randomized trials. 1

For high-risk patients, extend the SBT to 60-120 minutes for more accurate prediction of extubation success. 2 High-risk features include:

  • Prolonged mechanical ventilation (>14 days) 2
  • Chronic lung disease 2
  • Myocardial dysfunction 2
  • Previously failed extubation 2
  • Ineffective cough or impaired bulbar function 2

Monitoring and Termination Criteria

Terminate the SBT immediately if any of the following occur:

  • Respiratory distress or increased work of breathing 2
  • Hemodynamic instability 2
  • Oxygen desaturation 2
  • Altered mental status 2
  • Diaphoresis 2

Timing and Frequency

Conduct SBTs daily, ideally completing assessment before noon each day. 5 Daily spontaneous breathing trials in appropriately selected patients reduce the duration of mechanical ventilation. 4

Coordinate the SBT with a spontaneous awakening trial to optimize outcomes. 4

Post-Extubation Management

For high-risk patients who pass the SBT, use prophylactic noninvasive ventilation (NIV) immediately after extubation rather than standard oxygen therapy. 2, 3 This is a strong recommendation with moderate-quality evidence. 3

For hypercapnic respiratory failure, particularly in COPD patients, NIV facilitates weaning with:

  • Decreased mortality (RR 0.54) 2
  • Reduced weaning failure (RR 0.61) 2

Common Pitfalls to Avoid

Do not routinely calculate the rapid shallow breathing index to determine SBT readiness, as it is not necessary. 5

Do not increase FiO₂ during the SBT, as this defeats the purpose of assessing the patient's ability to breathe with minimal support. 5

Do not use T-piece alone as the initial SBT method unless there are specific contraindications to pressure support, as it may unnecessarily delay extubation. 3, 1

Do not skip the daily screening process even if the patient failed an SBT the previous day, as clinical status can change rapidly. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.